Results 251 to 260 of about 59,427 (290)

The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma. [PDF]

BMC Cancer
Deng W, Xie J, Wang T, Luo L, Zhu G, Xiao Y, Tao J, Lin L, Ge X, Wen W, Wang M, Yu B, Liu Y, Luo R, Wan R, Hu Z, Shan R.   +16 more
europepmc   +1 more source

Full-capped 12-S-atom TTP derivatives (BV-TTP, BE-TTP, EM-TTP and EV-TTP): syntheses, structures and charge transport properties [PDF]

CrystEngComm, 2015
Highly π-conjugated multi-sulfur molecules are tightly packed forming single-component organic crystals with remarkable conductivity.
Gang Xue, Xia Chen, Hong Lei, Hong-Feng Chen, Qi Fang   +4 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Advances in the management of TTP

Blood Reviews, 2022
Thrombotic thrombocytopenic purpura is an acute life-threatening disorder, associated with a mortality of 90% if unrecognised and untreated. The hallmark is thrombocytopenia and microangiopathic hemolytic anemia, with a blood film characterised by fragmented red cells and end organ damage.
M, Subhan, M, Scully
openaire   +2 more sources

TOD to TTP calibration [PDF]

SPIE Proceedings, 2011
The TTP (Targeting Task Performance) metric, developed at NVESD, is the current standard US Army model to predict EO/IR Target Acquisition performance. This model however does not have a corresponding lab or field test to empirically assess the performance of a camera system. The TOD (Triangle Orientation Discrimination) method, developed at TNO in The
Bijl, P., Reynolds, J.P., Vos, W.K., Hogervorst, M.A., Fanning, J.D.   +4 more
openaire   +2 more sources

ADAMTS13 and TTP

Current Opinion in Hematology, 2002
Thrombotic thrombocytopenic purpura (TTP) has been a mysterious and deadly disease that often could be treated effectively by plasma exchange, but without real understanding of the underlying pathophysiology. Recent advances now suggest that deficiency of a specific von Willebrand factor (VWF) cleaving protease promotes tissue injury in TTP.
Elaine M. Majerus, J. Evan Sadler, Xinglong Zheng   +2 more
openaire   +3 more sources

TTP and pregnancy [PDF]

Blood, 2014
In this issue of Blood, Jiang et al use the Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry to demonstrate that in women with a previous history of TTP, associated with severe ADAMTS13 deficiency, the frequency of TTP recurrence is low and pregnancy outcomes are positive ...
openaire   +2 more sources

Transient TTP in childhood

Pediatric Blood & Cancer, 2009
AbstractThrombotic thrombocytopenic purpura (TTP) is a type of microangiopathic hemolytic anemia that is uncommon in childhood. Adults with TTP have a high mortality rate unless they are treated with plasma exchange. There are few reports of children with acquired idiopathic TTP, and most of those children received some form of treatment. We describe a
Igal Fligman, Mark Weinblatt, Philip Scimeca, Naomi P. Moskowitz   +3 more
openaire   +3 more sources

Clinical and Laboratory Features of Patients with Acquired Thrombotic Thrombocytopenic Purpura: Fourteen Years of the Milan TTP Registry

Thrombosis and Haemostasis, 2019
Acquired thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy caused by the immune-mediated severe deficiency of ADAMTS13. We hereby report the demographic and disease-related data of acquired TTP patients recorded in the Milan ...
I. Mancini, S. Pontiggia, R. Palla, A. Artoni, C. Valsecchi, B. Ferrari, D. Miković, F. Peyvandi   +7 more
semanticscholar   +1 more source